OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 02, 2012
Contract API manufacturers and fine-chemical producers roll out capacity and service expansions.
A Q&A with Erik van den Berg, CEO of AM-Pharma, on recent industry trends.
China's drug-distribution network has been a mess for years, but government reforms and industry focus are unveiling new opportunities for market order and growth.
March 02, 2012
Brazil's generic-drug market is growing steadily.
The evolving bio/pharmaceutical business model poses risk for CMOs.
February 02, 2012
More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
Pharma announces plans for the year ahead at annual JPMorgan Global Healthcare conference.
As biopharmaceutical development and commercialization increases, companies are expanding their cold-chain capabilities.
Industry optimism is on the rise for 2012.
The Asian nation is strategizing to take the lead over its regional competitors in pharmaceutical exports.